Claire Pierra

1.0k total citations
37 papers, 763 citations indexed

About

Claire Pierra is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Claire Pierra has authored 37 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 21 papers in Epidemiology and 18 papers in Molecular Biology. Recurrent topics in Claire Pierra's work include HIV/AIDS drug development and treatment (29 papers), Biochemical and Molecular Research (18 papers) and Hepatitis C virus research (14 papers). Claire Pierra is often cited by papers focused on HIV/AIDS drug development and treatment (29 papers), Biochemical and Molecular Research (18 papers) and Hepatitis C virus research (14 papers). Claire Pierra collaborates with scholars based in France, United States and Italy. Claire Pierra's co-authors include Gilles Gosselin, Jean‐Pierre Sommadossi, Edward G. Bridges, Richard Storer, Raymond F. Schinazi, Erika Cretton-Scott, S. Benzaria, Jean‐Louis Imbach, David N. Standring and L Placidi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Claire Pierra

34 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Pierra France 15 421 376 374 258 160 37 763
S. Benzaria France 11 370 0.9× 183 0.5× 171 0.5× 335 1.3× 139 0.9× 25 638
Nghe Nguyen‐Ba Canada 16 600 1.4× 266 0.7× 297 0.8× 358 1.4× 301 1.9× 25 977
Brent Korba United States 13 171 0.4× 217 0.6× 134 0.4× 143 0.6× 78 0.5× 22 410
Sandrine Vendeville France 11 144 0.3× 195 0.5× 135 0.4× 184 0.7× 174 1.1× 15 519
Jayakanth Kankanala United States 19 302 0.7× 191 0.5× 55 0.1× 365 1.4× 303 1.9× 30 863
Daniel Brian Nichols United States 12 339 0.8× 130 0.3× 57 0.2× 214 0.8× 97 0.6× 18 701
Tse‐I Lin Sweden 11 276 0.7× 377 1.0× 480 1.3× 126 0.5× 63 0.4× 30 670
Meg Keilman United States 9 522 1.2× 482 1.3× 609 1.6× 319 1.2× 181 1.1× 12 1.1k
Alessia Petrocchi Italy 11 258 0.6× 92 0.2× 114 0.3× 298 1.2× 138 0.9× 18 561
Anastasia L. Khandazhinskaya Russia 15 344 0.8× 228 0.6× 28 0.1× 347 1.3× 288 1.8× 82 715

Countries citing papers authored by Claire Pierra

Since Specialization
Citations

This map shows the geographic impact of Claire Pierra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Pierra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Pierra more than expected).

Fields of papers citing papers by Claire Pierra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Pierra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Pierra. The network helps show where Claire Pierra may publish in the future.

Co-authorship network of co-authors of Claire Pierra

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Pierra. A scholar is included among the top collaborators of Claire Pierra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Pierra. Claire Pierra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dousson, Cyril B., Christopher Chapron, David N. Standring, et al.. (2011). 815 IDENIX NS5A HCV REPLICATION INHIBITORS WITH LOW PICOMOLAR, PAN-GENOTYPIC IN VITRO ANTIVIRAL ACTIVITY. Journal of Hepatology. 54. S326–S327. 7 indexed citations
3.
Pierra, Claire, Jean‐Pierre Sommadossi, Chiara Musiu, et al.. (2009). Synthesis and antiviral evaluation of thieno[3,4-d]pyrimidine C-nucleoside analogues of 2′,3′-dideoxy- and 2′,3′-dideoxy-2′,3′-didehydro-adenosine and -inosine. Bioorganic & Medicinal Chemistry. 17(6). 2321–2326. 8 indexed citations
4.
Standring, David N., Margareta Larsson, Claire Pierra, et al.. (2008). 67 POTENT ANTIVIRAL ACTIVITY OF SECOND GENERATION NUCLEOSIDE INHIBITORS, IDX102 AND IDX184, IN HCV-INFECTED CHIMPANZEES. Journal of Hepatology. 48. S30–S30. 16 indexed citations
5.
Hamann, Mark T., Claire Pierra, Richard Storer, et al.. (2008). Synthesis and study of 9-deazaguanosine derivatives as potential inhibitors of RNA virus replication. Nucleic Acids Symposium Series. 52(1). 603–604. 2 indexed citations
6.
Pierra, Claire, Agnès Amador, S. Benzaria, et al.. (2006). Synthesis and Pharmacokinetics of Valopicitabine (NM283), an Efficient Prodrug of the Potent Anti-HCV Agent 2‘-C-Methylcytidine. Journal of Medicinal Chemistry. 49(22). 6614–6620. 147 indexed citations
7.
Pierra, Claire, et al.. (2005). NM 283, AN EFFICIENT PRODRUG OF THE POTENT ANTI-HCV AGENT 2′-C-METHYLCYTIDINE. Nucleosides Nucleotides & Nucleic Acids. 24(5-7). 767–770. 52 indexed citations
8.
Pierra, Claire, S. Benzaria, David Dukhan, et al.. (2004). Synthesis, Physicochemical and Pharmacokinetic Studies of Potential Prodrugs of β-L-2′-Deoxycytidine, a Selective and Specific Anti-HBV Agent. Antiviral chemistry & chemotherapy. 15(5). 269–279. 3 indexed citations
9.
Benzaria, S., Claire Pierra, Dorothée Bardiot, et al.. (2003). Monoval-LdC: Efficient Prodrug of 2′-Deoxy-β-L-cytidine (L-dC), A Potent and Selective Anti-HBV Agent. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 1003–1006. 3 indexed citations
10.
Dukhan, David, Claire Pierra, S. Benzaria, et al.. (2003). 4′-C-Methyl-β-D-ribofuranosyl Purine and Pyrimidine Nucleosides Revisited. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 707–709. 6 indexed citations
11.
Hernández-Santiago, Brenda I., L Placidi, Achraf Al Faraj, et al.. (2002). Pharmacology of β- l -Thymidine and β- l -2′-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus. Antimicrobial Agents and Chemotherapy. 46(6). 1728–1733. 43 indexed citations
12.
Bryant, Martin L., Edward G. Bridges, L Placidi, et al.. (2001). ANTI-HBV SPECIFIC β-L-2′-DEOXYNUCLEOSIDES. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 597–607. 23 indexed citations
13.
Chu, Chung K., Li Ma, Süreyya Ölgen, et al.. (2001). ChemInform Abstract: Synthesis and Antiviral Activity of Oxaselenolane Nucleosides.. ChemInform. 32(10). 1 indexed citations
14.
Pierra, Claire, Jean‐Louis Imbach, Erik De Clercq, et al.. (2000). Synthesis and antiviral evaluation of some β-l-2′,3′-dideoxy-5-chloropyrimidine nucleosides and pronucleotides. Antiviral Research. 45(3). 169–183. 11 indexed citations
15.
Pierra, Claire, Süreyya Ölgen, Sócrates C.H. Cavalcanti, et al.. (2000). Synthesis and Antiviral Activities of Enantiomeric 1-[2-(Hydroxymethyl) Cyclopropyl] Methyl Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 253–268. 5 indexed citations
16.
Chu, Chung K., Li Ma, Süreyya Ölgen, et al.. (2000). Synthesis and Antiviral Activity of Oxaselenolane Nucleosides. Journal of Medicinal Chemistry. 43(21). 3906–3912. 49 indexed citations
17.
Pierra, Claire, Gilles Gosselin, J P Sommadossi, et al.. (1999). Stereospecific Synthesis and Antiviral Activities of β-L-2′,3′-Dideoxy-5-chloropyrimidine Nucleoside Derivatives. Nucleosides and Nucleotides. 18(4-5). 643–644.
18.
19.
Pelicano, Hélène, et al.. (1997). Enzymatic Properties of the Unnatural β-l-Enantiomers of 2‘,3‘-Dideoxyadenosine and 2‘,3‘-Didehydro-2‘,3‘-dideoxyadenosine. Journal of Medicinal Chemistry. 40(24). 3969–3973. 22 indexed citations
20.
Gosselin, Gilles, Claire Pierra, Jean‐Louis Imbach, et al.. (1997). New Unnatural L-Nucleoside Enantiomers:From Their Stereospecific Synthesis to Their Biological Activities. Nucleosides and Nucleotides. 16(7-9). 1389–1398. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Benzaria Breakdown of academic impact, for papers by Nghe Nguyen‐Ba Breakdown of academic impact, for papers by Brent Korba Breakdown of academic impact, for papers by Sandrine Vendeville Breakdown of academic impact, for papers by Jayakanth Kankanala Breakdown of academic impact, for papers by Daniel Brian Nichols Breakdown of academic impact, for papers by Tse‐I Lin Breakdown of academic impact, for papers by Meg Keilman Breakdown of academic impact, for papers by Alessia Petrocchi Breakdown of academic impact, for papers by Anastasia L. Khandazhinskaya
Rankless by CCL
2026